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Mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT) protein confer resistance to the antima-
larial drug chloroquine. PfCRT localizes to the parasite digestive vacuole, the site of chloroquine action, where it mediates resis-
tance by transporting chloroquine out of the digestive vacuole. PfCRT belongs to a family of transporter proteins called the chlo-
roquine resistance transporter family. CRT family proteins are found throughout the Apicomplexa, in some protists, and in
plants. Despite the importance of PfCRT in drug resistance, little is known about the evolution or native function of CRT pro-
teins. The apicomplexan parasite Toxoplasma gondii contains one CRT family protein. We demonstrate that T. gondii CRT
(TgCRT) colocalizes with markers for the vacuolar (VAC) compartment in these parasites. The TgCRT-containing VAC is a
highly dynamic organelle, changing its morphology and protein composition between intracellular and extracellular forms of
the parasite. Regulated knockdown of TgCRT expression resulted in modest reduction in parasite fitness and swelling of the
VAC, indicating that TgCRT contributes to parasite growth and VAC physiology. Together, our findings provide new informa-
tion on the role of CRT family proteins in apicomplexan parasites.
In the intraerythrocytic life stage, Plasmodium falciparum para-sites make a living by gaining energy from serum-derived glu-
cose and consuming hemoglobin from the host erythrocyte as a
source of amino acids (1). The hemoglobin is endocytosed and
transported to the parasite’s digestive vacuole (DV), a lysosome-
like compartment containing peptidases that break down hemo-
globin protein into its constituent amino acids (2). This digestion
process releases toxic heme subunits from the hemoglobin protein
into the DV. The parasite detoxifies these subunits by incorporat-
ing them into an inert crystalline substance called hemozoin (3).
The antimalarial drug chloroquine accumulates in this digestive
vacuole, where it acts by interfering with heme detoxification.
Chloroquine inhibits the formation of hemozoin, causing toxic
heme subunits to build up within the DV, eventually resulting in
parasite death (4).
Resistance to chloroquine is widespread and is mediated by
mutations in the so-called P. falciparum chloroquine resistance
transporter (PfCRT) (5, 6). PfCRT is a multipass membrane trans-
porter that localizes to the DV (5). Mutant PfCRT proteins are
able to transport chloroquine out of the DV, removing it from its
site of action and thereby ablating its toxic effects on the parasite
(7). PfCRT belongs to a family of transporter proteins called the
CRT family, which is part of the large drug/metabolite transporter
superfamily (8, 9). Homologues of PfCRT are found in all apicom-
plexan parasites, as well as in a range of other protists and plants.
The plant Arabidopsis thaliana contains three PfCRT homologues
called chloroquinelike transporters (CLT) (10). These homo-
logues localize to the A. thaliana plastid and regulate glutathione
metabolism, likely by transporting glutathione and -glutamyl-
cysteine between the cytoplasm and the plastid lumen (10).
The apicomplexan parasite Toxoplasma gondii contains one
homolog of PfCRT (TgCRT). Like A. thaliana, both P. falciparum
and T. gondii possess a plastid, termed the apicoplast. Unlike P.
falciparum, T. gondii does not contain a large digestive vacuole,
and the extent to which T. gondii uses endocytosis to sequester
metabolites from its host cell in a manner akin to Plasmodium
remains unclear.
In the work described in this paper, we investigated the local-
ization and function(s) of TgCRT to gain insights into the evolu-
tion and role of this family of transporters. We demonstrated that,
in intracellular parasites, TgCRT localized to highly dynamic ves-
icles that overlapped the markers for a lysosome-like vacuolar
compartment called the VAC (11). In extracellular parasites,
TgCRT localized to one or a few larger, vacuole-like compart-
ments that also overlapped the VAC markers. We generated a
regulatable knockdown of TgCRT expression and demonstrated
that, while TgCRT was not essential to the growth of T. gondii in
vitro, the loss of TgCRT resulted in a reduction in parasite fitness
and dilation of the VAC compartment.
MATERIALS AND METHODS
Identification of TgCRT. A BLASTP sequence similarity search using Pf-
CRT (accession number PF3D7_07090000, available at www.plasmodb
.org) as a query sequence identified the TgCRT genomic locus. This region
partially corresponds to that encoded by the annotated gene TGME49_
313930 (www.toxodb.org). Alignment of the predicted sequence to those
of other CRT-like proteins suggested the gene model was incorrect. We
therefore designed the primers 5=-ACTGCTCCACTGTTTTGCTTCG
and 5=-GACATGGCTGTAAAGGTCTTCGC to amplify the entire open
reading frame of TgCRT by PCR, using cDNA from RHHXGPRT strain
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T. gondii parasites as the template. We cloned and sequenced the resulting
PCR product.
Alignment and phylogenetic analysis. CRT homologues from a range
of organisms were identified by a BLASTP sequence similarity search with
PfCRT as the query sequence. We generated an initial alignment using
ClustalX 2.0.12 (12), followed by manual adjustment in JALVIEW version
11.0 (13). The maximum likelihood tree was created using PhyML version
3.0 (14).
Plasmid construction and parasite transfections. Details on the con-
struction of the various plasmids generated in this study, the selection
procedures to generate the various parasite strains, and the Southern blot-
ting approach are presented in the supplemental material.
Parasite culturing. Parasites were cultured in human foreskin fibro-
blast (HFF) cells grown in Dulbecco’s modified Eagle’s medium supple-
mented with 1% fetal calf serum and antibiotics. Where relevant, we
added anhydrotetracycline (ATc) to a final concentration of 0.5 g/ml.
SDS-PAGE and Western blotting. SDS-PAGE and Western blotting
were performed as described previously (15). Membranes were probed
with the following primary antibodies: rat antihemagglutinin (anti-HA)
antibody (clone 3F10, 1:1,000 dilution; Roche Applied Science), mouse
anti-green fluorescent protein (GFP) antibody (1:1,000; BD Biosciences),
rabbit anti-TgTOM40 antibody (1:1,000) (G.G.V.D., unpublished data),
rabbit anti-TgCPN60 antibody (1:5,000) (16), and mouse anti-TgGRA8
antibody (1:100,000) (a kind gift from Gary Ward, University of Ver-
mont) (17). We then probed with the following secondary antibodies:
anti-rabbit horseradish peroxidase (HRP) antibody (1:10,000), anti-rat
HRP antibody (1:1,000), and anti-mouse HRP antibody (1:200). Protein
bands were visualized using the Amersham ECL plus Western blotting
detection system (GE Healthcare). The mass of each band was calculated
from an Rf plot.
To generate antibodies specific to TgCRT, we PCR amplified a region
encompassing the C-terminal 198 amino acids of the TgCRT protein
using the primers 5=-GGGTCCTGGTTCGATGATCATGAAACGGCG
CGCC and 5=-CTTGTTCGTGCTGTTTATTATATACATCCGTTGTT
CGC. We inserted the resultant fragment into the pAVA421 vector (18) by
ligation-independent cloning and introduced the plasmid into Escherichia
coli strain BL21. The recombinant protein was purified by affinity chro-
matography using a Ni-nitrilotriacetic acid (NTA) agarose resin (Qiagen).
We generated polyclonal antiserum by inoculation into rabbits (Institute
of Medical and Veterinary Science, Adelaide, South Australia). We used
the antibody for Western blotting at a 1:200 dilution.
Sodium carbonate analysis. Intact membranes were isolated from
clonal parasites expressing TgCRT with a 3-HA epitope tag (TgCRT-HA3)
by incubation in 100 mM Na2CO3 at pH 11.5 as described previously (15).
Proteins extracted from both the membrane and soluble fraction were ana-
lyzed by SDS-PAGE and Western blotting as described previously (15).
Microscopy. Immunofluorescence assays were performed as de-
scribed previously (15). The primary antibodies were rat anti-HA anti-
body (clone 3F10, 1:100 dilution; Roche Applied Science), mouse anti-c-
myc antibody (clone 9E10, 1:200; Thermo Scientific), rabbit anti-T. gondii
vacuolar pyrophosphatase-1 (TgVP1) antibody (1:4,000; a kind gift from
Silvia Moreno, University of Georgia), guinea pig anti-T. gondii Na/H
exchanger 3 (TgNHE3) antibody (1:500; a kind gift from Gustavo Arriza-
balaga, Indiana University), rabbit anti-TgTOM40 antibody (1:2,000)
(G.G.V.D., unpublished data), rabbit anti-TgCPN60 antibody (1:1,000),
mouse anti-TgGRA8 antibody (1:100,000) (a kind gift from Gary Ward,
University of Vermont) (17), mouse anti-T. gondii inner membrane com-
plex (TgIMC) antibody (monoclonal antibody 45.36, 1:1,000; a kind gift
from Gary Ward, University of Vermont), rabbit anti-TgMIC5 antibody
(1:500) (19), and affinity-purified rabbit anti-TgCPL antibody (1:100)
(11). Secondary antibodies were anti-rat Alexa Fluor 488, anti-mouse
Alexa Fluor 546, anti-guinea pig Alexa Fluor 594, anti-rabbit Alexa Fluor
546, and anti-rabbit Alexa Fluor 594 antibodies (1:200 to 1:500; Life Tech-
nologies). Images were acquired on a Leica TCS SP2 inverted laser-scan-
ning confocal microscope or a Zeiss Axiovert Observer fluorescence mi-
croscope and linearly adjusted for contrast and brightness. For
extracellular immunofluorescence assays, free parasites were fixed in 3%
paraformaldehyde, affixed to coverslips using 0.1% polyethyleneimine,
and then prepared as described above.
For live-cell imaging, freshly lysed TgCRT-GFP-expressing parasites
were allowed to invade human foreskin fibroblast cells grown to conflu-
ence on coverslips. The parasites were grown in standard growth medium
overnight and then washed with growth medium to remove any remain-
ing extracellular parasites. Images were taken on a Leica TCS SP2 inverted
laser-scanning confocal microscope. For time-lapse imaging, parasites
were allowed to invade a host cell monolayer grown in glass bottom dishes
(MatTek) for 1 h. The sample was washed three times and replaced with
Evrogen antibleaching live-cell visualization medium (20). Images were
taken at 15-min intervals using a Zeiss Axiovert Observer inverted fluo-
rescence microscope. Cultures were maintained in a humidified environ-
ment at 37°C with 5 to 10% CO2 in air for the duration of imaging.
Parasite growth and competition assays. To measure parasite
growth, we performed plaque assays by adding 200 parasites to a 25-cm2
tissue culture flask containing a confluent monolayer of human foreskin
fibroblasts in the absence or presence of ATc. We grew parasites undis-
turbed for 9 days and performed plaque assays as described previously
(15). The plaque areas were determined for approximately 50 plaques
from each flask, and P values were calculated using a 2-tailed unpaired
Student’s t test. As a more quantitative measure of parasite growth, we
introduced a tandem-dimeric Tomato (tdTomato) red fluorescent pro-
tein into iTgCRT/TgCRT parasites (described below) by electroporation
and selected for parasites expressing the tdTomato RFP transgene by flow
cytometry (15). Flow cytometry was performed at the John Curtin School
of Medical Research (Australian National University). We measured par-
asite growth in the absence or presence of ATc using a Fluostar Optima
fluorescence plate reader as described previously (15, 21).
Competition assays were performed in triplicate by mixing mutant
iTgCRT/TgCRT parasites with parental iTgCRT/eTgCRT parasites (de-
scribed below) at a 1:1 ratio. The mixed culture was added to 25-cm2 tissue
culture flasks containing confluent human foreskin fibroblasts in the
presence or absence of ATc. Cultures were passed every 4 days, and im-
munofluorescence assays were performed every second pass. One hun-
dred vacuoles were counted from each culture, and the experiment was
performed in triplicate. Mutant parasites were distinguished from paren-
tal parasites by labeling with mouse anti-chloramphenicol acetyltrans-
ferase (CAT) antibodies (Abcam), with the CAT protein only present in
iTgCRT/TgCRT strain parasites.
Quantification of VAC size. Wild-type (RH) and iTgCRT/TgCRT
parasites were treated with 0.5 g/ml ATc for 2 days. Freshly lysed para-
sites were added to HFF cells, allowed to settle for 15 min at room tem-
perature, and then incubated at 37°C for 30 min for invasion. Noninvaded
parasites were washed away with phosphate-buffered saline. Infected HFF
cells were fixed with 4% paraformaldehyde and stained with affinity-pu-
rified rabbit anti-TgCPL antibodies (11) at a 1:100 dilution. Images were
captured with a Zeiss Axiovert Observer Z1 inverted fluorescence micro-
scope equipped with a 100, 1.3-numerical-aperture objective lens and
an AxioCAM MRm camera. The diameters of VAC compartments were
quantified using Zeiss Axiovision 4.3 software. For nonspherical VACs,
we measured the widest diameter. P values were calculated using an un-
paired Student’s t test.
GenBank nucleotide sequence accession number. The corrected
TgCRT cDNA sequence has been deposited in GenBank under accession
number KJ130040.
RESULTS
T. gondii contains one CRT family protein. To identify possible
homologues of PfCRT in Toxoplasma gondii, we performed
BLAST searches of the T. gondii genome (www.toxodb.org) using
PfCRT as a query sequence. We identified a single putative CRT
homologue encoded on chromosome XI and called this TgCRT. This
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corresponded to a gene previously included in an alignment of CRTs
from a range of organisms (22). To determine the correct coding
sequence of TgCRT, we amplified the entire open reading frame, us-
ing cDNA as a template. This revealed that the TgCRT model pre-
sented in toxoDB is incorrect. The correct sequence encodes a protein
of 890 amino acids, with a predicted mass of 92 kDa.
To elucidate the evolutionary relationships between CRT fam-
ily proteins, we performed a phylogenetic analysis on CRT family
proteins from apicomplexans, oomycetes, plants, red algae, and
amoebae. This revealed that TgCRT branches with CRT homo-
logues from related coccidian parasites, such as Eimeria tenella
and Neospora caninum (see Fig. S1A in the supplemental mate-
rial). We identified single CRT family proteins from each apicom-
plexan parasite that we examined, but the phylogenetic tree was
not sufficiently resolved to determine whether these represent a
monophyletic group. A multiple sequence alignment (see Fig.
S1B) reveals that the similarity of TgCRT to other CRT family
proteins resides in the central region of the protein, which spans
the 10 predicted transmembrane helices. Compared to CRT fam-
ily proteins from other organisms, coccidian CRT proteins harbor
extended N and C termini (see Fig. S1C). A key mutation that
confers chloroquine resistance in PfCRT is the conversion of
lysine 76 to a threonine (K76T) (5, 23). Intriguingly, TgCRT and
other coccidian CRTs harbor a threonine in this position (see Fig.
S1B). TgCRT, however, resembles wild-type PfCRT at several
other positions with a known role in conferring chloroquine
transport activity, such as N76 and N326 (see Fig. S1B) (23).
TgCRT contains numerous other regions that are conserved in
CRT homologues from other organisms, including a cysteine-rich
motif in the loop between transmembrane domains 7 and 8 (see
Fig. S1D).
TgCRT localizes to a population of dynamic vesicles. To ex-
amine the localization of TgCRT, we inserted an HA3 epitope tag
at the 3= end of the native TgCRT open reading frame in ku80 T.
gondii parasites (24, 25). We observed TgCRT-HA3 localizing to
multiple small puncta in intracellular parasites (Fig. 1A). Western
blot analysis of the resulting cell line revealed a protein with an
observed mass of 87 kDa (Fig. 1B), congruent with the predicted
mass of 92 kDa. Like other CRT family proteins, TgCRT contains
multiple predicted transmembrane domains (see Fig. S1B and C
in the supplemental material). To establish whether TgCRT is a
membrane-bound protein, we carried out a Na2CO3 partitioning
assay on the parasite line expressing TgCRT-HA3 (26). This assay
segregates integral membrane proteins from soluble and periph-
eral membrane proteins. TgCRT-HA3 partitioned into the inte-
gral membrane fraction (Fig. 1C), consistent with TgCRT being a
transmembrane protein. We conclude that TgCRT is an integral
membrane protein that resides in small, membrane-bound vesi-
cles in intracellular parasites.
To investigate the identity of the putative TgCRT-containing
vesicles, we colabeled TgCRT-HA3 with markers for several well-
described organelles in T. gondii tachyzoites, including the apico-
plast, mitochondrion, dense granules, and micronemes (Fig. 2A to
D). TgCRT-HA3 did not colocalize with any of these markers.
Earlier studies revealed that the proton-pumping vacuolar
ATPase of T. gondii (TgV-ATP) localizes to small vesicles that were
described as acidocalcisomes (27). To determine whether TgCRT
colocalizes with TgV-ATP, we inserted a c-myc epitope tag into
the 3= end of the open reading frame of subunit B of the V-ATP
(TgV-ATP-cmyc). We transfected this construct into the parasite
line already expressing TgCRT-HA3. Immunofluorescence assays
carried out on the resulting parasite line showed that TgCRT-HA3
and TgV-ATP-cmyc partially overlap in intracellular tachyzoites
(Fig. 2E, arrowheads). We next colabeled TgCRT-HA3 with anti-
bodies against vacuolar pyrophosphatase-1 (TgVP1), a marker for
the late endosomes in intracellular parasites (11, 28). We observed
essentially no overlap between these structures (Fig. 2F). As a sec-
ond marker for late endosomes, we colabeled TgCRT-HA3 para-
sites with antibodies against TgNHE3, a Na/H exchanger (29).
Again, we observed no overlap between these organelles (Fig. 2G).
The vesicular pattern of TgCRT labeling resembled that of the
fragmented VAC compartment described in intracellular para-
sites (11). We therefore colabeled TgCRT-HA3-expressing para-
sites with antibodies against TgCPL, a marker for the VAC. This
revealed considerable overlap between the two compartments
(Fig. 2H), suggesting that TgCRT is associated with the VAC.
TgCRT-containing organelles change morphology in extra-
cellular parasites. The lytic cycle of T. gondii alternates between
intracellular dividing cells and motile extracellular stages. The
VAC is highly dynamic in intracellular tachyzoites (11). During
most stages of the parasite lytic cycle, the VAC is fragmented into
multiple smaller vesicular structures, but it is seen as one or more
larger vacuolar structures in extracellular parasites. To observe
TgCRT localization in extracellular parasites, we performed im-
munofluorescence assays on parasites expressing TgCRT-HA3
and TgV-ATP-cmyc (Fig. 3A) or on TgCRT-HA3-expressing par-
asites colabeled with antibodies against TgVP1 (Fig. 3B), TgNHE3
(Fig. 3C), or TgCPL (Fig. 3D). Interestingly, the morphology of
the TgCRT-containing compartment is markedly different in ex-
tracellular tachyzoites. Consistent with previous observations of
the VAC (11), TgCRT-HA3 localization appears as one or a few
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FIG 1 TgCRT is an integral membrane protein that localizes to multiple ves-
icles in intracellular parasites. (A) Immunofluorescence assay of cells express-
ing C-terminally tagged native TgCRT (TgCRT-HA3) labeled with antibodies
against the HA epitope (green) and the inner membrane complex (IMC; red).
Scale bar, 3 m. (B) Anti-HA Western blot of cell line expressing TgCRT-HA3,
revealing a single protein band of an estimated 87 kDa. (C) Western blot of a
sodium carbonate extraction of TgCRT-HA3-expressing parasites showing to-
tal (T), soluble (S), and membrane (M) proteins. TgCRT partitions into the
membrane fraction. TgTOM40 and TgCPN60 are used as controls for mem-
brane and soluble proteins, respectively.
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larger vacuolar organelles in extracellular parasites (Fig. 3). Con-
versely, TgV-ATP-cmyc appears to localize to the plasma mem-
brane and cytoplasm rather than to any defined vesicular struc-
tures (Fig. 3A).
Previous studies have defined TgVP1 and TgNHE3 as markers
for the plant-like vacuole (PLV) (28, 29) in extracellular parasites.
We find that TgVP1 and TgNHE3 localize to a large vacuolar
structure in extracellular parasites that shows a close spatial asso-
ciation with the TgCRT-HA3 localization (Fig. 3B and C), al-
though in our hands, these structures are not overlapping. TgCRT
and TgCPL retain their colocalization in extracellular parasites
(Fig. 3D), consistent with TgCRT localization to the VAC.
To further explore the change in morphology between extra-
cellular and intracellular tachyzoites, we generated a parasite line
where TgCRT was fused to green fluorescent protein (GFP). This
allowed us to visualize the VAC in live parasites. Live-cell flu-
orescence images of intracellular T. gondii expressing TgCRT-
GFP reveal the presence of multiple small vesicles in intracellular
parasites (Fig. 4A), mirroring what we observed in epitope-tagged
parasites. In extracellular parasites, TgCRT-GFP localizes to a
larger vesicle and, occasionally, some smaller vesicles (Fig. 4B).
Western blotting reveals that TgCRT-GFP exists as a single
protein of 120 kDa, similar to the predicted mass of 124 kDa
(Fig. 4C).
Having established TgCRT-GFP as a robust marker for the
VAC compartment in live parasites, we next set out to characterize
the dynamics of the changes that occur in this compartment be-
tween extra- and intracellular stages by performing time-lapse im-
aging of TgCRT-GFP parasites. We allowed parasites to invade
host cells and then imaged single-cell vacuoles every 15 min for 7
h (Fig. 4D; see also Movie S1 in the supplemental material). Dur-
ing this time frame of intracellular growth, the large VAC com-
partment observed in extracellular parasites fragments substan-
tially. Notably, the VAC is fragmented before the parasite
undergoes its first round of cell division (Fig. 4D). To quantify
fragmentation of the VAC, we counted TgCRT-GFP-containing
vesicles in parasites at regular time intervals postinvasion (Fig.
4E). In extracellular parasites (time zero), TgCRT-GFP exists in an
average of approximately three separate compartments, typically
one larger compartment and some smaller ones. Eight hours post-
invasion, parasites typically have over a dozen smaller TgCRT-
GFP-containing vesicles. The relationship between vesicle number
and time postinvasion has a statistically significant Spearman’s rank
correlation coefficient of 0.752 (P  0.0001), suggesting a strong cor-
relation between time after invasion and vesicle number.
The role of TgCRT in parasite fitness and VAC morphology.
PfCRT has proven recalcitrant to genetic ablation, suggesting that
it may be essential to parasite survival (30). To determine whether
TgCRT is important for growth in T. gondii, we first generated a
parasite strain expressing an anhydrotetracycline (ATc)-regulated
TgCRT gene in TATi strain T. gondii parasites (31). This parental
cell line, termed iTgCRT/eTgCRT, expresses both native and ATc-
regulatable copies of TgCRT. We then deleted the 5= region of the
native TgCRT locus by double homologous recombination, using
a previously described cosmid recombineering system (32) to gen-
erate a parasite line, termed iTgCRT/TgCRT, that expresses only
the ATc-regulatable copy of TgCRT. Southern blot analysis of the
resulting cell line demonstrated successful disruption of the native
TgCRT locus (see Fig. S2 in the supplemental material).
To measure the regulation of TgCRT in the iTgCRT/TgCRT
FIG 2 TgCRT colocalizes with the T. gondii vacuole (VAC) compartment. Immunofluorescence assays of cell lines expressing TgCRT-HA3, labeled with anti-HA
antibody (green) and colabeled with anti-TgCPN60 antibody (red) to identify the apicoplast (A), anti-TgTOM40 antibody to identify the mitochondrion (B),
anti-TgGRA8 antibody to identify the dense granules (C), anti-TgMIC5 antibody to identify the micronemes (D), anti-c-myc antibody to identify C-terminally
c-myc-tagged subunit B of TgV-ATP (arrowheads indicate points of colocalization with TgCRT-HA3) (E), anti-TgVP1 antibody to identify the PLV/late
endosomes (F), anti-TgNHE3 antibody as a further marker for the PLV (G), and anti-TgCPL antibody to identify the VAC (H). Scale bars, 3 m.
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cell line, we incubated parasites in the absence of ATc (day 0) or
the presence of ATc for 1, 2, and 3 days and then performed West-
ern blotting to detect the HA-tagged TgCRT protein. After 1 day
on ATc, TgCRT levels are greatly reduced, and after 2 days, the
protein is undetectable (Fig. 5A), demonstrating robust down-
regulation of the protein in the iTgCRT/TgCRT cell line. To
compare the levels of ATc-regulated TgCRT expression to the
wild-type TgCRT level, we generated polyclonal antibodies
against TgCRT and probed proteins extracted from iTgCRT/
eTgCRT and iTgCRT/TgCRT cell lines grown with and without
ATc. In the absence of ATc in both cell lines, we observed bands of
the expected mass for TgCRT (Fig. 5B). When we knocked down
iTgCRT expression through the addition of ATc in the iTgCRT/
eTgCRT cell line, we observed a band corresponding to the ex-
pected mass for native TgCRT but at a reduced intensity compared
to that obtained when the ATc-regulatable copy of TgCRT is ex-
pressed (Fig. 5B). This suggests that there is overexpression of
TgCRT from the ATc-regulated promoter. Nevertheless, when we
cultured iTgCRT/TgCRT in the presence of ATc, TgCRT protein
was undetectable (Fig. 5B), indicating that the iTgCRT/TgCRT
strain allows strong depletion of TgCRT protein upon the addi-
tion of ATc.
To elucidate the importance of TgCRT for parasite growth and
viability, we performed plaque assays on the iTgCRT/TgCRT
and iTgCRT/eTgCRT parasite lines. Parasites were added to a
monolayer of human foreskin fibroblast cells and grown for 9 days
in the presence or absence of ATc. Over this time, parasites will
form zones of clearance in the host cell monolayer, which become
apparent upon staining with crystal violet dye. The sizes of the
plaques indicate how well the parasites have grown during this
time. We found that iTgCRT/TgCRT grew in both the absence
and presence of ATc, suggesting that TgCRT is not essential for
parasite growth (Fig. 6A). Quantification of plaque size revealed
that plaques of the iTgCRT/TgCRT parasite line grown in the
presence of ATc were on average smaller than those of iTgCRT/
TgCRT parasites grown in the absence of ATc (P  0.0001)
phase TgCRT-HA3 TgV-ATP merge
phase TgCRT-HA3 TgVP1 merge
phase TgCRT-HA3 TgCPL merge
A.
B.
D.
phase TgCRT-HA3 TgNHE3 mergeC.
FIG 3 TgCRT-containing vesicles change their morphology in extracellular parasites. Immunofluorescence assays of extracellular parasites expressing TgCRT-
HA3, colabeled with antibodies against TgV-ATP (A), TgVP1, a marker for the PLV (B), TgNHE3, a second marker for the PLV (C), and TgCPL, a marker for the
VAC (D). Scale bars, 3 m.
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(Fig. 6B). This effect is likely specifically due to the depletion of
TgCRT from this cell line, since we observed little difference in
plaque size upon the addition of ATc to the parental iTgCRT/
eTgCRT cell line (P  0.05) (Fig. 6B).
As a more quantitative measure of parasite growth, we in-
troduced a superbright tdTomato fluorescent protein into the
iTgCRT/TgCRT cell line. We added parasites to wells of a
96-well plate and measured the fluorescence intensity of each
well on a daily basis, with the fluorescence in each well corre-
lating directly to parasite growth (15, 21). The iTgCRT/
TgCRT parasites grew 	30% more slowly in the presence of
ATc (Fig. 6C), again supporting a minor role for TgCRT in
parasite growth.
These data suggested a fitness cost associated with the loss of
TgCRT in T. gondii parasites. To test this, we performed a compe-
tition assay where parental iTgCRT/eTgCRT and iTgCRT/
TgCRT mutant parasites were mixed in a 1:1 ratio and then
grown in the presence or absence of ATc. We could distinguish
mutant from parental parasites by performing immunofluores-
cence assays to detect the presence of chloramphenicol acetyl-
transferase, which is only present in the mutant. We monitored
the parasites over 24 days. During this time, the ratio of the two
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FIG 4 The large vacuole in extracellular parasites breaks down after host cell invasion. Live confocal images of intracellular (A) and extracellular (B) parasites
expressing TgCRT-GFP. (C) Anti-GFP Western blot of cell line expressing TgCRT-GFP. TgCRT-GFP appears as a band of approximately 120 kDa. (D) Individual
frames from time-lapse imaging of a single live cell using fluorescence microscopy. Parasites expressing TgCRT-GFP were allowed to invade host cells for 1 h and
then imaged every 15 min postinvasion (P.I.). Scale bar, 3 m. (E) Quantification of the numbers of CRT-containing vesicles in parasites at regular intervals
postinvasion, represented as a dot plot.
Toxoplasma Chloroquine Resistance Transporter
November 2014 Volume 13 Number 11 ec.asm.org 1365
 on January 20, 2015 by A
ustralian N
ational U
niv.
http://ec.asm
.org/
D
ow
nloaded from
 
parasite strains grown in the absence of ATc remained approxi-
mately 1:1 (Fig. 6D). In contrast, iTgCRT/TgCRT parasites were
rapidly outcompeted in the presence of ATc, with less than 5%
remaining after 24 days (Fig. 6D).
Our data indicate that TgCRT is not essential for parasite
growth but that loss of TgCRT does incur a fitness cost on the
parasite. We also demonstrate that TgCRT localizes to the VAC
compartment. We wondered whether loss of TgCRT would result
in morphological changes to the VAC. To test this, we performed
immunofluorescence assays to label the VAC in wild-type (RH)
and iTgCRT/TgCRT parasites grown in the absence and pres-
ence of ATc. We focused on recently invaded parasites in which
the VAC was still in its larger, extracellularlike form. We noted
that the VAC appeared larger in parasites lacking TgCRT (Fig.
7A). To quantify this, we measured the diameter of the VAC and
found that the VAC of iTgCRT/TgCRT parasites grown in the
presence of ATc was on average 1.3 m in diameter, significantly
larger than the average 0.73-m diameter found in parasites
grown without ATc (Fig. 7B) (P  0.0001). We observed no such
difference in wild-type parasites. Together, these results suggest
that the loss of TgCRT leads to an enlargement of the VAC com-
partment, suggesting an effect on the physiology of this organelle.
DISCUSSION
The CRT protein family is found in a diverse array of eukaryotes.
In plants, chloroquine-like transporters localize to the plastid,
where they appear to play a role in glutathione homeostasis and
metabolism, possibly by mediating glutathione export from the
organelle (10). In erythrocytic stages of Plasmodium, CRT pro-
teins localize to the digestive vacuole (DV) (5), a lysosome-like
organelle that functions primarily in the digestion of hemoglobin
(33, 34). The DV houses a suite of proteases that digest hemoglo-
bin into its constituent amino acids, which are then utilized for
parasite growth (1, 33). In Plasmodium, chloroquine accumulates
in the DV and interferes with the polymerization of heme released
from hemoglobin (4, 35). Heme in its free state is highly toxic to
the parasite (36). Failure to polymerize heme results in swelling of
the DV and rapid parasite death (37, 38). Mutant CRT alleles in P.
falciparum confer resistance to the major antimalarial drug chlo-
roquine by transporting chloroquine from the DV (5, 7).
In this study, we characterized the CRT homologue from the
model apicomplexan T. gondii, revealing that TgCRT localizes to
the recently described VAC compartment (11). The VAC is a pro-
teolytic compartment that houses cathepsin-like cysteine pro-
teases, such as TgCPL and TgCPB (11, 39). Using a live-cell-imag-
ing approach, we demonstrated that the VAC is a highly dynamic
compartment. In extracellular and recently invaded parasites, it
typically exists as a single large compartment, which then appar-
ently fragments into a dozen or more smaller TgCRT-containing
vesicles during parasite replication.
We demonstrate here that the TgCRT-labeled VAC is distinct
from the plant-like vacuole (PLV) in intra- and extracellular par-
asites. TgVP1 was described as the seminal marker of the PLV in T.
gondii (28). In a parallel study, TgCPL was reported to be a marker
of the VAC (11). Both studies reported that intracellular replicat-
ing parasites show TgVP1 associated with markers of late endo-
somes, whereas TgCPL was seen in multiple vesicular structures
attributed to fragmentation of the resident organelle (11, 28).
However, in extracellular parasites, these markers were reported
to colocalize in the PLV in one study (28) but were observed sep-
arately in the VAC (TgCPL) and late endosome (TgVP1) in the
parallel study (11). The discrepant findings were attributed to the
dynamic nature of these endolysosomal organelles and possible
fusion of the VAC with late endosomes to form the PLV. Regard-
less, these studies provided evidence for multiple functions of the
PLV and VAC organelles, including roles in regulating ion balance
in response to changes in the extracellular environment and pro-
teolytic processing or digestion of proteins. In this study, we have
used the term VAC when referring to a compartment(s) associ-
ated with TgCPL, while PLV has been used to indicate structures
associated with TgVP1.
The proteomic makeup of the VAC appears quite dynamic.
The vacuolar H-pumping ATPase associates with some TgCRT-
containing vesicles in intracellular parasites, suggesting that these
are acidic compartments. In extracellular parasites, however, the
association between the VAC and the vacuolar H-pumping
ATPase is not apparent. In a similar vein, a previous study dem-
onstrated that TgCPL and TgCPB do not always colocalize to the
same intracellular vesicles (39), and we find that the same is true of
TgCPL and TgCRT (Fig. 2H). Notably, we find that TgCRT does
not overlap with TgVP1 and TgNHE3, markers for the PLV (28,
29). This is perhaps surprising, given that the PLV exists as a large
vacuole in extracellular parasites that morphologically resembles
the extracellular TgCRT-containing vacuole (28). Clearly, more
work is required to better define the protein composition and
functions of both the TgCRT-containing VAC compartment and
the PLV.
The intracellular TgCRT-associated VAC compartments ex-
hibit numerous intriguing similarities to the DV of Plasmodium
(Fig. 8). In addition to the presence of CRT homologues in both
the VAC and DV, both compartments house cathepsin proteases,
TgCPL and TgCPB in the case of the VAC and falcipains 2a, 2b,
and 3 in the case of the DV (40). During intracellular replication,
both compartments also harbor a V-type H-pumping ATPase
that likely functions in maintaining the acidity of the organelle
iHA-TgCRT
GRA8
0 1 2 3
days on ATc
TgCRT
GRA8
ATc +- +-
iTgCRT-HA3/
eTgCRT
iTgCRT-HA3/
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A.
B.
FIG 5 Regulatable knockdown of TgCRT. (A) Western blot analysis of the
iTgCRT/TgCRT mutant cell line to determine the extent of iTgCRT down-
regulation upon the addition of ATc. Parasites were grown from 0 to 3 days on
ATc and probed with antibodies against iHA-TgCRT, as well as antibodies
against GRA8 as a loading control. (B) Western blot analysis of iTgCRT/
eTgCRT and iTgCRT/TgCRT cell lines grown in the absence and presence of
ATc. Parasites were probed with anti-CRT antibodies, as well as anti-GRA8
antibodies as a loading control.
Warring et al.
1366 ec.asm.org Eukaryotic Cell
 on January 20, 2015 by A
ustralian N
ational U
niv.
http://ec.asm
.org/
D
ow
nloaded from
 
(41). Given these similarities, we hypothesize that the common
ancestor of Plasmodium and Toxoplasma may have harbored an
acidic lysosome-like vacuole that gave rise to the VAC in T. gondii
and the DV in Plasmodium (Fig. 8).
Despite this possible shared ancestry, some of the functions of
the DV and VAC differ in their respective parasites. The DV of
Plasmodium functions primarily in the proteolytic digestion of
hemoglobin. Endocytic vesicles carrying hemoglobin from the
erythrocyte form at a cytosome and are internalized into the par-
asite (42). These endocytic vesicles are acidified and contain pro-
teases that can digest hemoglobin. Ultimately, the endocytic ves-
icles fuse to form the larger DV, where the bulk of hemoglobin
digestion in the parasite takes place (42). There is currently limited
evidence that tachyzoites of T. gondii perform endocytosis. The
function of proteases, such as TgCPL and TgCPB, and the func-
tions of the VAC more generally remain poorly defined. Knockout
of TgCPL partially impairs the proteolytic maturation of TgCPB
and certain microneme proteins, suggesting a role in protein ac-
tivation (11, 39). While falcipains are maturases for plasmepsin
aspartyl proteases in the DV (43), they have not been linked to the
maturation of microneme proteins. Our hypothesis that the T.
gondii VAC and the Plasmodium DV are homologous organelles
may provide a framework for understanding possible functions of
the VAC, although much research remains to confirm the evolu-
tionary link between these organelles.
Although the role of mutant PfCRT alleles in chloroquine
transport is clear (7), the native function of CRT homologues in
apicomplexans remains to be elucidated. Unpublished attempts
to knock out PfCRT were unsuccessful (30), suggesting that
PfCRT may be essential for P. falciparum survival in erythrocytic
stages. Knockdown of chloroquine-resistant PfCRT protein levels
to approximately 65% of the wild-type levels lessened parasite
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FIG 6 TgCRT is not essential for T. gondii growth, but depletion of TgCRT imparts a fitness cost on parasites. (A) Plaque assays of iTgCRT/eTgCRT and
iTgCRT/TgCRT cell lines grown in the absence and presence of ATc. (B) Quantification of the relative areas of plaques in the parental and mutant cell lines
grown in the absence and presence of ATc. These are represented as box and whisker plots, with the medians indicated by vertical bars, the 1st and 3rd quartiles
forming the box, and whiskers indicating the minimum and maximum values. ****, P  0.0001; n.s., not significant. (C) Fluorescence growth assay of
iTgCRT/TgCRT parasites grown in the absence and presence of ATc over 7 days. Error bars each represent one standard deviation from the mean of three
technical replicates. (D) Competition assay of iTgCRT/eTgCRT and iTgCRT/TgCRT parasites grown in the absence and presence of ATc. Parasites were mixed
in a 1:1 ratio at the start of the experiment, and the percentages of iTgCRT/TgCRT parasites in the population were monitored over 24 days, as a percentage of
parasites expressing the CAT protein. Error bars each indicate one standard deviation from the mean.
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resistance to chloroquine and led to an alkalinization of the DV
(30), suggesting a possible role for CRT in acidification of this
compartment. Plant chloroquine-like transporters function in
transporting glutathione, and a recent study implicates chloro-
quine-resistant PfCRT (but not chloroquine-sensitive PfCRT) in
glutathione transport into the DV (10, 44).
In this study, we demonstrate that TgCRT is not essential for
the growth of T. gondii under standard in vitro culture condi-
tions. Although our data suggest robust knockdown of TgCRT in
the iTgCRT/TgCRT parasite line compared to wild-type levels
(Fig. 6B), we cannot rule out that a small amount of TgCRT is
expressed that is sufficient for TgCRT function. Nevertheless,
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FIG 7 Loss of TgCRT results in swelling of the VAC. (A) Representative images of wild-type (RH) and iTgCRT/TgCRT parasites grown in the absence and
presence of ATc and labeled with anti-CPL antibodies to highlight the VAC. (B) Quantification of VAC diameters in wild-type and iTgCRT/TgCRT parasites
grown in the presence and absence of ATc. ****, P  0.0001; n.s., not significant.
FIG 8 Similarities between the VAC compartment of T. gondii and the digestive vacuole of Plasmodium. In addition to the presence of CRT family proteins, both
the VAC and digestive vacuole contain cathepsin-like cysteine proteases, such as the Plasmodium falcipains, TgCPL and TgCPB. Both compartments are acidic,
with this acidity maintained through the function of a V-type H-pumping ATPase (V-ATP). CQ, chloroquine; Hb, hemoglobin; Hz, hemozoin.
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competition growth assays revealed that the loss of TgCRT im-
parts a fitness cost to the parasite. Intriguingly, a reduction in
TgCRT levels results in an enlargement of the VAC compartment.
The reasons for this remain unclear. It is possible that TgCRT has
a role in the biogenesis or homeostasis of the VAC. For example,
the loss of TgCRT may influence the pH of the VAC (much like
depletion of PfCRT alters the pH in the DV of Plasmodium [30]),
which in turn could influence ion regulation and lead to swelling
of the organelle. Notably, we have previously demonstrated that
treatment of T. gondii with agents that cause alkalinization of
acidic compartments (bafilomycin A1, which inhibits V-type H-
ATPases, and chloroquine) disrupts some of the functions of the
VAC and leads to swelling of this compartment (11).
It is equally possible that the loss of TgCRT leads to an accu-
mulation of the native substrate transported by TgCRT, which in
turn causes VAC swelling. Another possibility is that TgCRT, like
plant chloroquine-like transporters and chloroquine resistance al-
leles of PfCRT (10, 44), has a role in transporting glutathione.
Dysregulation of glutathione functions in the VAC may then lead
to the swelling of this organelle.
P. falciparum parasites harboring chloroquine resistance alleles
of PfCRT are less fit than strains with chloroquine-sensitive
PfCRT. Cessation of chloroquine treatment in areas where chlo-
roquine resistance is prevalent frequently leads to the reemergence
of chloroquine-sensitive P. falciparum strains (e.g., see reference
45). More recently, this reemergence has been duplicated in a
laboratory environment (46). The latter study performed compe-
tition growth assays with chloroquine-sensitive and -resistant
strains of P. falciparum in the absence of chloroquine. The study
found that chloroquine-sensitive strains almost entirely outcom-
peted resistant strains over an 	70-day time frame (46). This mir-
rors our findings with T. gondii parasites that were depleted of
TgCRT. The same study examined the metabolic differences be-
tween chloroquine-sensitive and -resistant strains of P. falciparum
and found that parasites harboring chloroquine resistance alleles
accumulated hemoglobin-derived peptides (46). This suggests
that parasites carrying mutated forms of PfCRT are less efficient in
catabolizing hemoglobin, which may in turn affect parasite amino
acid pools and result in the observed decrease in fitness.
Less clear is how these observed phenotypes correspond to the
function of PfCRT (46). As we have proposed for the effects of the
TgCRT mutant on VAC function, it is possible that mutated forms
of PfCRT perturbed DV function and this led to impairment of
hemoglobin digestion. Another possibility is that PfCRT func-
tions as a peptide (or amino acid) transporter, with impairment of
the transporter then leading to the accumulation of peptides in the
DV. In this context, it is certainly intriguing that glutathione,
which is transported by plant chloroquine-like transporters (10),
is a tripeptide. Could TgCRT be functioning as a peptide or amino
acid transporter? Given the presence of proteases like TgCPL and
TgCPB, it is conceivable that one function of the VAC is in protein
catabolism, with peptides or amino acids derived from this pro-
cess contributing to overall parasite amino acid pools. T. gondii is
auxotrophic for many amino acids (47), which are primarily de-
rived from the growth medium by in vitro cultures. We tested
whether TgCRT knockdown parasites had impaired growth in
amino acid-depleted medium but observed no differences com-
pared to the growth of parasites that expressed TgCRT (not
shown). This does not rule out the possibility that TgCRT func-
tions as a peptide or amino acid transporter—it could be that the
contribution of the VAC to overall amino acid pools is minimal or
that peptide or amino acid transport from the VAC is important to
maintain VAC functions.
In this study, we have examined the localization and possible
functions of TgCRT, with a view to elucidating the origin and
evolution of CRT family proteins. CRT family proteins localize to
lysosome-like vacuolar organelles in both T. gondii and Plasmo-
dium. In T. gondii, the VAC compartment to which TgCRT local-
izes is a highly dynamic structure, potentially involved in numer-
ous roles within the parasite. CRT family proteins exist in a range
of other organisms, presenting opportunities to further explore
the function(s) of this important group of transporters.
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